康基醫療控股有限公司 09997Prospectus Information

Prospectus Information
IPO Timeline
Broker Results (T-2)
2020-06-24
Some brokers release in afternoon
Grey Market (T-1)
2020-06-26
Afternoon
HKEX Allotment (T-1)
2020-06-26
Evening
Registrar Allotment (T-1)
2020-06-26
Evening
Listing Day (T)
2020-06-29
First day of trading
Company Overview
Stock Name康基醫療控股有限公司
Stock Code09997
Company Full Name康基醫療控股有限公司
Industry醫療保健
Principal Activities主要在中國從事微創外科手術器械及配件的設計、開發、制造及銷售業務。
Listing Date2020-06-29
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國浙江省杭州市桐廬經濟開發區春江東路1668號
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.kangjimedical.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 13.88 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)
Cornerstone Share40.9%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 1,564,276,000
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 27.6
First Day OpenHK$ 25.9
First Day Change98.85%
First Day Volume126791000.0
First Day Turnover3308090000.0
Use of Proceeds
Use of Proceeds1、約20.0%(或591.1百萬港元),將用于提升產能及加強制造能力; 2、約25.0%(或738.9百萬港元),將用于為我們的研發活動提供資金; 3、約20.0%(或591.1百萬港元),將用于投資我們的銷售及營銷活動; 4、約25.0%(或738.9百萬港元),將用于在未來五年內為補充及擴大我們產品 組合及技術的潛在戰略投資及收購提供資金; 5、約10.0%(或295.6百萬港元),將用于營運資金及一般公司用途。
Underwriting Syndicate
Joint Sponsors (3)
高盛(亚洲)有限责任公司 CE ACC536 中信证券(香港)有限公司 CE AAK249 Merrill Lynch (Asia Pacific) Limited CE AAC198
Overall Coordinators (3)
高盛(亚洲)有限责任公司 CE ACC536 中信里昂证券有限公司 CE AAB893 Merrill Lynch (Asia Pacific) Limited CE AAC198
Joint Bookrunners (3)
高盛(亚洲)有限责任公司 CE ACC536 中信里昂证券有限公司 CE AAB893 Merrill Lynch (Asia Pacific) Limited CE AAC198
Joint Lead Managers (3)
高盛(亚洲)有限责任公司 CE ACC536 中信里昂证券有限公司 CE AAB893 Merrill Lynch (Asia Pacific) Limited CE AAC198
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 BlackRock Funds 271,249,900 HKD 8.67% 6 months 2020-12-29
2 Cormorant Global Healthcare Master Fund, LP 116,251,940 HKD 3.72% 6 months 2020-12-29
3 Fidelity International 348,776,640 HKD 11.15% 6 months 2020-12-29
4 Hillhouse Funds 116,251,940 HKD 3.72% 6 months 2020-12-29
5 Lake Bleu Prime Healthcare Master Fund Limited 193,750,920 HKD 6.19% 6 months 2020-12-29
6 Oaktree Funds 116,251,940 HKD 3.72% 6 months 2020-12-29
7 OrbiMed Funds 116,251,940 HKD 3.72% 6 months 2020-12-29
Directors & Management
Chairman鐘鳴
Company Secretary溫兆強
No director data available.
Major Shareholders
Major Shareholders & Holdings鐘鳴(51.40%);TPG Keyhole, L.P.(17.36%)
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics